Scientists launch first human test of Next-Generation HIV vaccines
NCT ID NCT06919016
Summary
This is the first human trial testing two new experimental HIV vaccines. Researchers want to see if the vaccines are safe and if they trigger a helpful immune response in healthy volunteers. The study will follow 45 HIV-negative adults for about 16 months, checking for side effects and measuring how their immune systems react.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital (Site ID: 30007)
Boston, Massachusetts, 02215, United States
-
Columbia P&S CRS (Site ID: 30329)
New York, New York, 10032, United States
-
Seattle Vaccine and Prevention CRS (Site ID: 30331)
Seattle, Washington, 98104, United States
-
The Hope Clinic of the Emory Vaccine Center CRS (Site ID: 31440)
Decatur, Georgia, 30030, United States
-
University of Alabama Medical Center (Site ID: 31788)
Birmingham, Alabama, 35222, United States
-
University of Pittsburgh (Site ID: 1001)
Pittsburgh, Pennsylvania, 15213, United States
-
University of Rochester Medical Center (Site ID: 31467)
Rochester, New York, 14642, United States
-
Vanderbilt University Medical Center (Site ID: 30352)
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.